Dr. Yin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
243 Charles St
Boston, MA 02114Phone+1 617-523-7900
Education & Training
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Cornea, External Diseases, and Refractive Surgery, 2015 - 2017
Detroit Medical Center/Wayne State UniversityResidency, Ophthalmology, 2012 - 2015- Detroit Medical Center/Wayne State University (Sinai-Grace)Internship, Transitional Year, 2011 - 2012
Wayne State UniversityPh.D., Vision science, 2008
Capital University of Medical SciencesClass of 2003
Certifications & Licensure
MA State Medical License 2015 - 2025
MI State Medical License 2011 - 2015- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- Nerve Growth Factor Treatment for Neurotrophic Keratopathy in IRIS® Registry.Asmaa A Zidan, Joshua B Gilbert, Eric Goldberg, Connor Ross, Tobias Elze
Ophthalmology. 2024-11-07 - Efficacy of Amniotic Membrane Grafting for the Treatment of Chemical and Thermal Ocular Surface Injuries: A Report by the American Academy of Ophthalmology.Peter B Veldman, Mark A Greiner, Maria S Cortina, Anthony N Kuo, Jennifer Y Li
Ophthalmology. 2024-10-09 - Safety and Efficacy of Epithelium-Off Corneal Collagen Cross-Linking for the Treatment of Corneal Ectasia: A Report by the American Academy of Ophthalmology.Maria S Cortina, Mark A Greiner, Anthony N Kuo, Jennifer Y Li, Darby D Miller
Ophthalmology. 2024-10-01
Journal Articles
- Association of Α-melanocyte–Stimulating Hormone with Corneal Endothelial Cell Survival During Oxidative Stress and Inflammation-Induced Cell Loss in Donor TissueUla V Jurkunas, Jia Yin, Reza Dana, JAMA Ophthalmology
Press Mentions
Your Red, Itchy Eyes Might Be from a Condition Called Pinguecula — Here's How to TellFebruary 5th, 2021- Dana-Farber Collaborates with Mass. Eye and Ear to Rebuild Damaged Corneas Using Patients’ Own Stem Cells for First Time in United StatesSeptember 1st, 2020
- Cell Therapy That Repairs Cornea Damage with Patient’s Own Stem Cells Achieves Positive Phase I Trial ResultsAugust 19th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
